Glucagon-Like Peptide-2 in the Control of Gastrointestinal Motility: Physiological Implications

被引:10
|
作者
Baccari, Maria Caterina [1 ]
Vannucchi, Maria Giuliana
Idrizaj, Eglantina [1 ]
机构
[1] Univ Florence, Sect Physiol Sci, Dept Expt & Clin Med, Viale GB Morgagni 63, I-50134 Florence, Italy
关键词
Glucagon-like peptide-2; acetylcholine; gastrointestinal motility; neuromodulation; nitric oxide; substance P; vasoactive intestinal peptide; VASOACTIVE-INTESTINAL-PEPTIDE; GLP-2 RECEPTOR EXPRESSION; NITRIC-OXIDE; ENTERIC NEURONS; LIPID ABSORPTION; IN-VIVO; RELAXIN; LOCALIZATION; NO; NEUROTRANSMISSION;
D O I
10.2174/1389203723666220217142935
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucagon-Like Peptide-2 (GLP-2) is a pleiotropic hormone that plays several roles in different organs and tissues, so being involved in many physiological processes. Among these, it regulates gastrointestinal (GI) tract function binding to a specific G-protein coupled receptor (GLP-2R). Of note, GLP-2R is widely expressed in different cells of the GI tract, including excitatory and inhibitory neurons of the enteric nervous system. In the gut, GLP-2 has been reported to play numerous actions, among which the modulation of motility. Nevertheless, most of the GLP-2 effects and its role in physiological processes are still debated. The aim of this minireview is to summarize the data present in the literature on the control of GI motility by GLP-2, the mechanism through which it occurs, and to discuss the physiological implications of such effects. A better understanding of the role of GLP-2 on GI motor responses may be of importance for the development of new therapeutic approaches in GI dysmotility.
引用
收藏
页码:61 / 69
页数:9
相关论文
共 50 条
  • [1] Glucagon-like peptide-2
    Estall, Jennifer L.
    Drucker, Daniel J.
    ANNUAL REVIEW OF NUTRITION, 2006, 26 : 391 - 411
  • [2] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [3] Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
    Lutz, Thomas A.
    Osto, Elena
    CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 257 - 263
  • [4] The dimerization of glucagon-like peptide-2 MIMETIBODY™ is linked to leucine-17 in the glucagon-like peptide-2 region
    E. Baker, Audrey
    Sague, Sarah
    Grygiel, Tami L. R.
    Schmidt, Albert
    Rogers, Alison
    Jiang, Haiyan
    Kruszynski, Marian
    Nesspor, Tom
    JOURNAL OF MOLECULAR RECOGNITION, 2012, 25 (03) : 155 - 164
  • [5] Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs
    Wojdemann, M
    Wettergren, A
    Hartmann, B
    Holst, JJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 (08) : 828 - 832
  • [6] A biological function for glucagon-like peptide-2
    Hussain, MA
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (03) : 265 - 267
  • [7] The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas
    de Heer, J.
    Pedersen, J.
    Orskov, C.
    Holst, J. J.
    DIABETOLOGIA, 2007, 50 (10) : 2135 - 2142
  • [8] The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease
    Hornby, Pamela J.
    Moore, Beverley A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (05) : 637 - 646
  • [9] Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart
    Angelone, T.
    Filice, E.
    Quintieri, A. M.
    Imbrogno, S.
    Amodio, N.
    Pasqua, T.
    Pellegrino, D.
    Mule, F.
    Cerra, M. C.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (06) : 486 - 494
  • [10] The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas
    J. de Heer
    J. Pedersen
    C. Ørskov
    J. J. Holst
    Diabetologia, 2007, 50 : 2135 - 2142